Bolu Abant Izzet Baysal Training and Research Hospital, Department of Pathology - Bolu, Turkey.
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e20230191. doi: 10.1590/1806-9282.20230191. eCollection 2023.
Tumor budding is currently thought to be associated with worse prognosis. This study aims to examine tumor budding in invasive ductal-type breast carcinoma and its relationship with other clinicopathological parameters and overall survival.
All the H&E slides of 198 patients were re-evaluated for the histological grade, angiolymphatic invasion, perineural invasion, lymph node status, extranodal extension, multicentricity, pT, presence of the tumor budding, tumor budding score (i.e., low, intermediate, or high). Overall survival was considered the period after surgery until death. SPSS was used for statistical analysis.
Tumor budding was identified in 98 (49.5%) patients. Tumor budding score was low in 41 (41.8%) of 98 cases, intermediate in 25 (25.5%), and high in 32 (32.7%). We determined a strong correlation between tumor budding and poor prognostic variables such as tumor size, pT stage, angiolymphatic invasion, perineural invasion, number of metastatic axillary lymph nodes, overall survival, and extranodal tumor extension in metastatic lymph nodes. This strong correlation was also present for the tumor budding score.
Tumor budding may be a prognostic indicator for breast cancer.
肿瘤芽突目前被认为与预后不良有关。本研究旨在研究浸润性导管型乳腺癌中的肿瘤芽突及其与其他临床病理参数和总生存的关系。
对 198 例患者的所有 H&E 切片重新评估组织学分级、血管淋巴管侵犯、神经周围侵犯、淋巴结状态、结外扩展、多中心性、pT、肿瘤芽突存在、肿瘤芽突评分(低、中或高)。总生存时间被定义为手术后到死亡的时间。使用 SPSS 进行统计分析。
在 98 例(49.5%)患者中发现了肿瘤芽突。98 例中有 41 例(41.8%)肿瘤芽突评分低,25 例(25.5%)肿瘤芽突评分中等,32 例(32.7%)肿瘤芽突评分高。我们发现肿瘤芽突与肿瘤大小、pT 分期、血管淋巴管侵犯、神经周围侵犯、腋窝转移淋巴结数量、总生存时间和转移性淋巴结中的结外肿瘤扩展等不良预后变量之间存在很强的相关性。肿瘤芽突评分也存在很强的相关性。
肿瘤芽突可能是乳腺癌的预后指标。